Steffen-Sebastian Bolz, M.D., Ph.D., is a scientist, physician, and entrepreneur. He is a Co-Founder and Chief Scientific Officer of Aphaia Pharma AG and Founder and Chief Scientific and Medical Officer at Qanatpharma AG. Steffen-Sebastian holds a full professorship at the University of Toronto, is a Principal Investigator at the Ted Rogers Centre for Heart Research, and is Director of the Toronto Centre for Microvascular Medicine. Steffen-Sebastian holds a medical degree and a doctorate from the universities of Lübeck and Munich, Germany.